← Back to directory

Susanne K. Kjær

Researcher Next ID · RN-021385

Researcher · Medicine

University of Copenhagen

Copenhagen, Denmark

Not currently recruitingFunding unknown
Works count
1,065
Citation count
48,335
H-index
104
i10-index
580

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Cervical Cancer and HPV Research
Ovarian cancer diagnosis and treatment
Endometrial and Cervical Cancer Treatments
BRCA gene mutations in cancer
Genital Health and Disease

Publications

  • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

    The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30298-3

  • Dose-Response Association of CD8 + Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

    JAMA Oncology · 2017 · https://doi.org/10.1001/jamaoncol.2017.3290

  • Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

    The Lancet · 2017 · 10.1016/s0140-6736(17)31821-4

  • Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

    Clinical Infectious Diseases · 2016 · 10.1093/cid/ciw354

  • Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014

    European Journal of Cancer · 2016 · https://doi.org/10.1016/j.ejca.2016.10.015

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    PLoS ONE · 2015 · https://doi.org/10.1371/journal.pone.0128106

  • A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

    New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1405044

  • Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population

    Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.61.2408

  • Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

    The Lancet Infectious Diseases · 2015 · 10.1016/s1473-3099(14)71073-4

  • Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium

    JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/djt431

  • A high and increasing HPV prevalence in tonsillar cancers in E astern D enmark, 2000–2010: The largest registry‐based study to date

    International Journal of Cancer · 2014 · https://doi.org/10.1002/ijc.29254

  • ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer

    JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/dju149

  • GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

    Nature Genetics · 2013 · https://doi.org/10.1038/ng.2564

  • Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

    Nature Communications · 2013 · https://doi.org/10.1038/ncomms2629

  • Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

    The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70253-5

  • Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

    Endocrine Related Cancer · 2013 · https://doi.org/10.1530/erc-12-0395

  • Updating the Natural History of Human Papillomavirus and Anogenital Cancers

    Vaccine · 2012 · 10.1016/j.vaccine.2012.05.089

  • Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

    The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(11)70404-1

  • Risk of Birth Abnormalities in the Offspring of Men With a History of Cancer: A Cohort Study Using Danish and Swedish National Registries

    JNCI Journal of the National Cancer Institute · 2011 · https://doi.org/10.1093/jnci/djq550

  • Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

    JNCI Journal of the National Cancer Institute · 2010 · 10.1093/jnci/djq356

  • Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

    JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djp534

  • A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

    Nature Genetics · 2010 · https://doi.org/10.1038/ng.668

  • A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

    Nature Genetics · 2009 · https://doi.org/10.1038/ng.424

  • The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

    The Journal of Infectious Diseases · 2009 · 10.1086/597307

  • Multiple Loci With Different Cancer Specificities Within the 8q24 Gene Desert

    JNCI Journal of the National Cancer Institute · 2008 · https://doi.org/10.1093/jnci/djn190

  • Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

    Vaccine · 2008 · https://doi.org/10.1016/j.vaccine.2008.05.064

  • Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

    BMJ · 2008 · 10.1136/bmj.a1754

  • Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions

    Vaccine · 2008 · 10.1016/j.vaccine.2008.06.021

  • The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus–Positive, Cytologically Normal Women Over a 10-Year Period

    Cancer Research · 2006 · https://doi.org/10.1158/0008-5472.can-06-1057

  • Chapter 5: Updating the natural history of HPV and anogenital cancer

    Vaccine · 2006 · 10.1016/j.vaccine.2006.06.018

  • Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18

    Virology · 2004 · 10.1016/j.virol.2003.12.027

  • Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia

    JNCI Monographs · 2003 · 10.1093/oxfordjournals.jncimonographs.a003476

  • Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

    BMJ · 2002 · 10.1136/bmj.325.7364.572

  • Ginger treatment of hyperemesis gravidarum

    European Journal of Obstetrics & Gynecology and Reproductive Biology · 1991 · 10.1016/0028-2243(91)90202-v

Current projects

    No projects listed.